AZD6738 (ceralasertib) is anotherATR inhibitor that has shown antitumor activity in combination with DNA-damaging anticancer agents [8], such as cisplatin, causing rapid regression of ATM-deficient non-small cell lung cancer (NSCLC) xenograft models [87]. This evidence concerns the gene ATM and non-small cell lung carcinoma.